Literature DB >> 30054609

Association of Definitive Pelvic Radiation Therapy With Survival Among Patients With Newly Diagnosed Metastatic Cervical Cancer.

Yuefeng Wang1, Michael Farmer1, Enrique W Izaguirre1, David L Schwartz1, Bradley Somer2, Todd Tillmanns3, Matthew T Ballo1.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 30054609      PMCID： PMC6143011          DOI： 10.1001/jamaoncol.2018.2677

Source DB:  PubMed          Journal:  JAMA Oncol        ISSN： 2374-2437            Impact factor:   31.777


× No keyword cloud information.
  6 in total

1.  Outcomes and patterns of relapse after definitive radiation therapy for oligometastatic cervical cancer.

Authors:  Matthew S Ning; Vamsi Ahobila; Anuja Jhingran; Shane R Stecklein; Michael Frumovitz; Kathleen M Schmeler; Patricia J Eifel; Ann H Klopp
Journal:  Gynecol Oncol       Date:  2017-10-28       Impact factor: 5.482

2.  Improved Survival With Prostate Radiation in Addition to Androgen Deprivation Therapy for Men With Newly Diagnosed Metastatic Prostate Cancer.

Authors:  Chad G Rusthoven; Bernard L Jones; Thomas W Flaig; E David Crawford; Matthew Koshy; David J Sher; Usama Mahmood; Ronald C Chen; Brian F Chapin; Brian D Kavanagh; Thomas J Pugh
Journal:  J Clin Oncol       Date:  2016-06-20       Impact factor: 44.544

3.  Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer.

Authors:  M Morris; P J Eifel; J Lu; P W Grigsby; C Levenback; R E Stevens; M Rotman; D M Gershenson; D G Mutch
Journal:  N Engl J Med       Date:  1999-04-15       Impact factor: 91.245

4.  Survival of Cervical Cancer Patients Presenting with Occult Supraclavicular Metastases Detected by FDG-Positron Emission Tomography/CT: Impact of Disease Extent and Treatment.

Authors:  Yevgeniya J Ioffe; Leslie Stewart Massad; Matthew A Powell; Andrea R Hagemann; David G Mutch; Premal H Thaker; Julie K Schwarz; Perry W Grigsby
Journal:  Gynecol Obstet Invest       Date:  2017-04-08       Impact factor: 2.031

5.  Analysis of survival by tumor response.

Authors:  J R Anderson; K C Cain; R D Gelber
Journal:  J Clin Oncol       Date:  1983-11       Impact factor: 44.544

6.  Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study.

Authors:  Daniel R Gomez; George R Blumenschein; J Jack Lee; Mike Hernandez; Rong Ye; D Ross Camidge; Robert C Doebele; Ferdinandos Skoulidis; Laurie E Gaspar; Don L Gibbons; Jose A Karam; Brian D Kavanagh; Chad Tang; Ritsuko Komaki; Alexander V Louie; David A Palma; Anne S Tsao; Boris Sepesi; William N William; Jianjun Zhang; Qiuling Shi; Xin Shelley Wang; Stephen G Swisher; John V Heymach
Journal:  Lancet Oncol       Date:  2016-10-24       Impact factor: 41.316
  6 in total
  8 in total

1.  Brachytherapy and survival in small cell cancer of the cervix and uterus.

Authors:  Alexander J Lin; Comron Hassanzadeh; Stephanie Markovina; Julie Schwarz; Perry Grigsby
Journal:  Brachytherapy       Date:  2018-12-15       Impact factor: 2.362

2.  Detection of distant metastatic disease by positron emission tomography with 18F-fluorodeoxyglucose (FDG-PET) at initial staging of cervical carcinoma.

Authors:  Alexander Lin; Sirui Ma; Farrokh Dehdashti; Stephanie Markovina; Julie Schwarz; Barry Siegel; Matthew Powell; Perry Grigsby
Journal:  Int J Gynecol Cancer       Date:  2019-02-09       Impact factor: 3.437

3.  Incorporation of whole pelvic radiation into treatment of stage IVB cervical cancer: A novel treatment strategy.

Authors:  Victoria Perkins; Kathleen Moore; Sara Vesely; Koji Matsuo; Sayedamin Mostofizadeh; Travis T Sims; Jayanthi Lea; Dominique Barnes; Sixia Chen; Matthew Carlson; Lynda Roman; Bradley J Monk; Laura L Holman
Journal:  Gynecol Oncol       Date:  2019-12-04       Impact factor: 5.304

4.  SFN Enhanced the Radiosensitivity of Cervical Cancer Cells via Activating LATS2 and Blocking Rad51/MDC1 Recruitment to DNA Damage Site.

Authors:  Shiyu Wang; Yanan Wang; Xiangnan Liu; Yongbin Yang; Sufang Wu; Yuan Liu
Journal:  Cancers (Basel)       Date:  2022-04-08       Impact factor: 6.575

5.  Survival, treatment pattern, and treatment outcome in patients with cervical cancer metastatic to distant lymph nodes.

Authors:  Haoliang Lin; Dongyan Wang; Hui Li; Chuling Wu; Fengqian Zhang; Zhongqiu Lin; Tingting Yao
Journal:  Front Oncol       Date:  2022-08-11       Impact factor: 5.738

6.  Impact of sites versus number of metastases on survival of patients with organ metastasis from newly diagnosed cervical cancer.

Authors:  Zhuomin Yin; Huarong Tang; Li Li; Juan Ni; Shuhui Yuan; Hanmei Lou; Ming Chen
Journal:  Cancer Manag Res       Date:  2019-08-16       Impact factor: 3.989

7.  Impact of Metastasectomy and Aggressive Local Therapy in Newly Diagnosed Metastatic Soft Tissue Sarcoma: An Analysis of the NCDB.

Authors:  Mustafa Abugideiri; James Janopaul-Naylor; Jeffrey Switchenko; Sibo Tian; William Read; Robert Press; Shervin Oskouei; Nickolas Reimer; Matthew Ferris; Richard J Cassidy; Madhusmita Behera; David Monson; Jerome Landry; Karen D Godette; Pretesh R Patel
Journal:  Ann Surg Oncol       Date:  2021-07-16       Impact factor: 5.344

8.  Comparison of Chemotherapy vs Chemotherapy Plus Total Hysterectomy for Women With Uterine Cancer With Distant Organ Metastasis.

Authors:  Yuefeng Wang; Todd Tillmanns; Noam VanderWalde; Bradley Somer; Ari VanderWalde; Lee Schwartzberg; Matthew T Ballo
Journal:  JAMA Netw Open       Date:  2021-07-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.